Quest Diagnostics SEC filings, summarized
We read every Quest Diagnostics 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track DGX in your inbox
Add Quest Diagnostics to your watchlist — free, every morning.
Recent filings
Quest Diagnostics Reports Q2 Growth and Raises 2026 Guidance
Quest Diagnostics reported second-quarter 2026 revenue of $3.04 billion, up 10.2% year over year, with reported diluted EPS of $2.84 and adjusted diluted…
Quest Diagnostics ($DGX) filed a Form 8‑K on Mar 12, 2026 — Item 9.01 lists exhibits: Press release dated…
Quest Diagnostics ($DGX) filed a Form 8‑K on Mar 12, 2026 — Item 9.01 lists exhibits: Press release dated Mar 12, 2026 (Ex.99.1) and Inline XBRL cover page…
Quest Diagnostics ($DGX) disclosed (Reg FD) that Mr.
Quest Diagnostics ($DGX) disclosed (Reg FD) that Mr. Wentworth was elected to its Board of Directors. Press release is attached as Exhibit 99.1 and…
On Mar 9, 2026 Quest Diagnostics ($DGX) added Timothy Wentworth, former CEO of Walgreens Boots Alliance,…
On Mar 9, 2026 Quest Diagnostics ($DGX) added Timothy Wentworth, former CEO of Walgreens Boots Alliance, to its Board. He was appointed to the Compensation…
Quest Diagnostics ($DGX) filed a Form 8-K on Feb 10, 2026 attaching a press release with Q4 & FY 2025…
Quest Diagnostics ($DGX) filed a Form 8-K on Feb 10, 2026 attaching a press release with Q4 & FY 2025 results for the quarter and full year ended Dec 31,…
Quest Diagnostics ($DGX) Board of Directors authorized an additional $1.0B of common stock repurchases…
Quest Diagnostics ($DGX) Board of Directors authorized an additional $1.0B of common stock repurchases under its ongoing program — announced Feb 10, 2026.…
Quest Diagnostics ($DGX) filed an 8‑K (Item 2.02) on Feb 10, 2026 announcing Q4 and full‑year results for…
Quest Diagnostics ($DGX) filed an 8‑K (Item 2.02) on Feb 10, 2026 announcing Q4 and full‑year results for the period ended Dec 31, 2025; press release…
Quest Diagnostics ($DGX) filed a Form 8‑K on Jan 12, 2026 — Item 9.01 lists Exhibit 99.1: Presentation…
Quest Diagnostics ($DGX) filed a Form 8‑K on Jan 12, 2026 — Item 9.01 lists Exhibit 99.1: Presentation dated Jan 12, 2026, and Exhibit 104: cover page in…
Quest Diagnostics ($DGX) will present on strategy, performance and market trends at the 44th Annual J.P.
Quest Diagnostics ($DGX) will present on strategy, performance and market trends at the 44th Annual J.P. Morgan Healthcare Conference on Jan 12, 2026 —…
Quest Diagnostics filed a Form 8‑K on 2026‑01‑12: Item 2.02 says results of operations and financial…
Quest Diagnostics filed a Form 8‑K on 2026‑01‑12: Item 2.02 says results of operations and financial condition info are incorporated by reference from Item…